Need Help?

T200 sequencing Phase Ib of olaparib and capivasertib

T200 sequencing (Phase Ib of olaparib and capivasertib)

Request Access

Phase 1b of O and C DAC

These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC): The University of Texas MD Anderson Cancer Center 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) prior to any significant changes to the protocol for the Project. 14. The User Institution will notify DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC) may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than DAC FOR HIGH-GRADE SEROUS OVARIAN CANCER (MDACC). In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004930 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00004964076 bam 6.2 GB
EGAF00004964077 bam 4.3 GB
EGAF00004964078 bam 6.4 GB
EGAF00004964079 bam 3.9 GB
EGAF00004964080 bam 4.7 GB
EGAF00004964081 bam 3.5 GB
EGAF00004964082 bam 4.7 GB
EGAF00004964083 bam 5.1 GB
EGAF00004964084 bam 3.3 GB
EGAF00004964085 bam 7.1 GB
EGAF00004964086 bam 6.7 GB
EGAF00004964087 bam 3.4 GB
EGAF00004964088 bam 8.1 GB
EGAF00004964089 bam 4.9 GB
EGAF00004964090 bam 4.4 GB
EGAF00004964091 bam 6.9 GB
EGAF00004964092 bam 4.4 GB
EGAF00004964093 bam 7.8 GB
EGAF00004964094 bam 6.3 GB
EGAF00004964095 bam 4.5 GB
EGAF00004964096 bam 3.0 GB
EGAF00004964097 bam 3.7 GB
EGAF00004964098 bam 3.5 GB
EGAF00004964099 bam 5.8 GB
EGAF00004964100 bam 5.2 GB
EGAF00004964101 bam 7.2 GB
EGAF00004964102 bam 4.2 GB
EGAF00004964103 bam 6.3 GB
EGAF00004964104 bam 7.5 GB
EGAF00004964105 bam 3.2 GB
EGAF00004964106 bam 7.3 GB
EGAF00004964107 bam 4.5 GB
EGAF00004964108 bam 6.4 GB
EGAF00004964109 bam 3.1 GB
EGAF00004964110 bam 3.5 GB
EGAF00004964111 bam 6.4 GB
EGAF00004964112 bam 6.4 GB
EGAF00004964113 bam 7.2 GB
EGAF00004964114 bam 5.3 GB
EGAF00004964115 bam 5.0 GB
EGAF00004964116 bam 3.8 GB
EGAF00004964117 bam 7.0 GB
EGAF00004964118 bam 5.1 GB
EGAF00004964119 bam 4.4 GB
EGAF00004964120 bam 4.4 GB
EGAF00004964121 bam 3.8 GB
EGAF00004964122 bam 3.8 GB
EGAF00004964123 bam 4.5 GB
EGAF00004964124 bam 6.1 GB
EGAF00004964125 bam 3.7 GB
EGAF00004964126 bam 5.5 GB
EGAF00004964127 bam 7.1 GB
EGAF00004964128 bam 6.8 GB
EGAF00004964129 bam 4.7 GB
EGAF00004964130 bam 6.6 GB
EGAF00004964131 bam 6.8 GB
EGAF00004964132 bam 4.0 GB
EGAF00004964133 bam 3.6 GB
EGAF00004964134 bam 3.2 GB
EGAF00004964135 bam 4.1 GB
EGAF00004964136 bam 3.5 GB
EGAF00004964137 bam 6.5 GB
EGAF00004964138 bam 5.0 GB
EGAF00004964139 bam 4.0 GB
EGAF00004964140 bam 5.6 GB
EGAF00004964141 bam 3.4 GB
EGAF00004964142 bam 7.2 GB
EGAF00004964143 bam 4.4 GB
EGAF00004964144 bam 5.9 GB
EGAF00004964145 bam 3.8 GB
EGAF00004964146 bam 9.6 GB
EGAF00004964147 bam 3.1 GB
EGAF00004964148 bam 7.3 GB
EGAF00004964149 bam 6.3 GB
EGAF00004964150 bam 4.3 GB
EGAF00004964151 bam 6.8 GB
EGAF00004964152 bam 8.2 GB
EGAF00004964153 bam 7.1 GB
EGAF00004964154 bam 2.9 GB
EGAF00004964155 bam 5.9 GB
EGAF00004964156 bam 4.3 GB
EGAF00004964157 bam 6.4 GB
EGAF00004964158 bam 5.5 GB
EGAF00004964159 bam 3.3 GB
EGAF00004964160 bam 4.6 GB
EGAF00004964161 bam 3.1 GB
EGAF00004964162 bam 3.7 GB
EGAF00004964163 bam 7.4 GB
EGAF00004964164 bam 4.4 GB
EGAF00004964165 bam 3.8 GB
EGAF00004964166 bam 3.6 GB
EGAF00004964167 bam 4.4 GB
EGAF00004964168 bam 7.1 GB
EGAF00004964169 bam 6.4 GB
EGAF00004964170 bam 5.1 GB
EGAF00004964171 bam 4.1 GB
EGAF00004964172 bam 4.0 GB
EGAF00004964173 bam 7.8 GB
EGAF00004964174 bam 3.9 GB
EGAF00004964175 bam 4.7 GB
EGAF00004964176 bam 4.0 GB
EGAF00004964177 bam 7.9 GB
EGAF00004964178 bam 3.2 GB
EGAF00004964179 bam 5.9 GB
EGAF00004964180 bam 3.6 GB
EGAF00004964181 bam 6.5 GB
EGAF00004964182 bam 6.3 GB
EGAF00004964183 bam 8.0 GB
EGAF00004964184 bam 6.3 GB
EGAF00004964185 bam 8.0 GB
EGAF00004964186 bam 3.9 GB
EGAF00004964187 bam 5.7 GB
EGAF00004964188 bam 3.6 GB
EGAF00004964189 bam 3.1 GB
EGAF00004964190 bam 4.1 GB
EGAF00004964191 bam 4.1 GB
EGAF00004964192 bam 6.6 GB
EGAF00004964193 bam 4.0 GB
EGAF00004964194 bam 3.2 GB
EGAF00004964195 bam 3.2 GB
EGAF00004964196 bam 5.9 GB
EGAF00004964197 bam 3.9 GB
EGAF00004964198 bam 4.9 GB
EGAF00004964199 bam 4.4 GB
EGAF00004964200 bam 3.2 GB
EGAF00004964201 bam 3.9 GB
EGAF00004964202 bam 6.7 GB
EGAF00004964203 bam 6.3 GB
EGAF00004964204 bam 3.1 GB
EGAF00004964205 bam 6.2 GB
EGAF00004964206 bam 3.4 GB
EGAF00004964207 bam 3.8 GB
EGAF00004964208 bam 2.0 GB
EGAF00004964209 bam 4.3 GB
EGAF00004964210 bam 6.0 GB
EGAF00004964211 bam 6.0 GB
EGAF00004964212 bam 7.3 GB
EGAF00004964213 bam 3.7 GB
EGAF00004964214 bam 4.7 GB
EGAF00004964215 bam 6.7 GB
EGAF00004964216 bam 5.1 GB
EGAF00004964217 bam 3.6 GB
EGAF00004964218 bam 4.5 GB
EGAF00004964219 bam 6.0 GB
EGAF00004964220 bam 3.4 GB
EGAF00004964221 bam 5.9 GB
EGAF00004964222 bam 4.1 GB
EGAF00004964223 bam 7.2 GB
EGAF00004964224 bam 5.0 GB
EGAF00004964225 bam 5.6 GB
EGAF00004964226 bam 7.0 GB
EGAF00004964227 bam 6.3 GB
EGAF00004964228 bam 5.4 GB
EGAF00004964229 bam 6.5 GB
EGAF00004964230 bam 5.2 GB
EGAF00004964231 bam 4.5 GB
EGAF00004964232 bam 3.8 GB
EGAF00004964233 bam 5.3 GB
EGAF00004964234 bam 7.2 GB
EGAF00004964235 bam 3.9 GB
EGAF00004964236 bam 5.7 GB
EGAF00004964237 bam 4.2 GB
162 Files (832.0 GB)